David Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy

Size: px
Start display at page:

Download "David Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy"

Transcription

1 David Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy It s no dream. Sleep well without sleeping pills.

2 Outline Baby boomers & beyond: medication use Deprescribing Sleeping pills benefit:risk Sleep well without sleeping pills

3 Why take medications? Necessary for health Improving symptoms Managing chronic conditions (e.g. diabetes, high blood pressure, chronic pain) Prolonging life expectancy 3

4 As we get older We often need to take more medications to manage chronic conditions The benefits and risks of medications may change 4

5 As we get older The brain becomes more sensitive to drug effects Medications stay longer in our body less muscle more body fat liver and kidneys not as efficient as when we were younger Higher concentrations of medications body contains less water & muscle 5

6 Report 2018

7 Medication use in Canadians 65+

8 Medication use in Canadians 65+

9 Medication side effects can be serious, resulting in hospitalizations If 65+ taking the following number of medication classes: Probability of being hospitalized due to adverse effects in 2016 was: in in in in 35

10 Today s new terms: 1. DEPRESCRIBING 2. POTENTIALLY INAPPROPRIATE MEDICATIONS (PIMS)

11 Deprescribe Reducing and stopping medications to improve health and reduce adverse effect burden and risk. Potentially Inappropriate Medications Identified as a medication with high risk for harm, especially in older adults, when safer management alternatives exist.

12 PIM examples Chronic use of anti-inflammatory medications such as ibuprofen or naproxen (non-steroidal anti-inflammatory drugs or NSAIDs) Antipsychotic medication when used as a sleeping pill or for dementia (e.g. quetiapine/seroquel, risperidone/risperdal ) Long-acting sulfonylureas (type-2 diabetes medications) (e.g. glyburide/diabeta ) Sleeping pills (e.g. alprazolam/xanax, zolpidem/sublinox ) Stomach pills for more than 8 weeks in acid reflux disease : proton-pump inhibitors (e.g. pantoprazole/pantoloc ) 12

13 Potentially Inappropriate Medications (PIMs) Canadians 65+ who take at least one PIM Morgan et al CMAJ Open; 4: E346-E51. 13

14 How effective are sleeping pills?

15 22 7 Z-drug -42 Placebo -20 Huevo-Medina et al. BMJ 2012 Change in time to fall asleep (min.)

16 14 Placebo +35 Z-drug +49 Huevo-Medina et al. BMJ 2012 Increase in total sleep time (min.)

17 Drug-drug interaction fact When opioids are used with sleeping pills, the risk of death increases. New York Times U.S. data: What fraction of deaths involving opioids in people 65+ also included sleeping pills? ~2/3rds Humphries. NEJM Feb 22,

18 THE TRUE COST OF SEDATIVE-HYPNOTIC USE

19 How safe are sleeping pills? Safety with other prescription medications, cough & cold remedies, alcohol, pain killers?

20 How safe are sleeping pills? Risk for falls, injuries, pneumonia,

21 How safe are sleeping pills? Worries, social withdrawal, isolation, loneliness Risky driving, automobile accidents, loss of independence

22 How safe are sleeping pills? Memory problems, cognitive impairment Cognitive decline

23 How safe are sleeping pills? The vicious cycle of medication use, dependence, and withdrawal

24 Proportion of seniors who are chronic users of benzodiazepines (& 4-year trend) B.C. 7% 8.6% Alta. 1.2% 15.8% 12% Man. 0.5% 15.7% 13% 1.0% Sask. 5% 5.3% 1.1% Chronic users: one or more claims for a benzodiazepine or other related drug (i.e., z-drug) in a given year, totalling at least 90 continuous supply days, without a gap in supply of at least 30 days Ont. 7% 8.7% 1.9% Canada 10.4% 1.5% Qc. 21%* N.B. 25% P.E.I 8% 25.1% 0.9% N.L. 21% 20.9% 1.3% N.S. 15% 16.4% 0.5% 58% above Canadian avg. Source: Canadian Institute for Health Information *Self report (Qc.)

25 The cost of falls 1/3 rd of fall-related hospitalizations in people 65+ involve hip fractures Source: CIHI 2014 Preventing Falls: From Evidence to Improvement in Canadian Health Care.

26 Population Attributive Risk of Benzodiazapines for Injurious Falls resulting in hospitalization Injurious falls in 85+ yo: BZDs account for >30% (men) and >40% (women) Injurious falls in year olds: BZDs account for ~5% (men) to ~10% (women) Panneman MJ et al. Drugs Aging. 2003

27 to reduce the potentially inappropriate use of sedative-hypnotics

28 American College of Physicians 2016 ACP recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder. (Grade: strong recommendation, moderate-quality evidence) European Sleep Research Society 2017 CBT-I is recommended as first-line treatment for chronic insomnia in adults of any age (strong recommendation, high-quality evidence). A pharmacological intervention can be offered if CBT-I is not effective or not available.

29 Empower brochure

30 EMPOWER Tannenbaum et al. JAMA Intern Med 2014 Patients Initial invitation Design ~75 yo, 10 meds/day BZRA ~10 yrs Use: insomnia 60%; anxiety 50% Pharmacists: letter followed by phone call Referral to study team if interested. In-home meeting and consent. Cluster RCT (30 pharmacies) N 303 Intervention Outcomes Booklet (by mail) 6 mo. d/c (>3 mo. no BZRA) 6 mo. dose reduction or d/c

31 Direct Patient Education: BZD use months Intervention Usual care D/C BZD 27% 4.5% D/C & dose reduction BZD 38% 11% Tannenbaum et al. JAMA Intern Med 2014

32 You May Be at Risk EMPOWER brochure 8 page booklet Self-efficacy theory Components Self assessment of risks Education: BZRA harms Create cognitive dissonance Stories: augment self-efficacy Effective alternative Guidance: tapering

33 mysleepwell.ca It s no dream. Sleep well without sleeping pills. mysleepwell.ca

34 THERAPIST depression Insomnia and pain ONLINE older adults adults menopause fibromyalgia adolescents cancer BOOK stop hypnotics anxiety APP

35

36 36

37 Go! To Sleep mysleepwell.ca 37

38

39

40

41 Booklet 1 How To Get Your Sleep Back Booklet 2 How to Stop Sleeping Pills

42

43 mysleepwell.ca

44 What can you do? Educate yourself about what medications you are taking and why. Engage in a discussion with your health care provider about deprescribing options and alternate therapies. Spread the word about deprescribing to friends and family, advocacy groups and government representatives. Ask questions, stay informed, be proactive, and participate in making smart choices. 44

45 Resources Download information on how you can stop certain medications at deprescribingnetwork.ca *Also available in French 45

46 Discussion It s no dream. Sleep well without sleeping pills.

Canadian Deprescribing Network

Canadian Deprescribing Network Canadian Deprescribing Network 2017 Annual Report 1 What s deprescribing? Deprescribing is the planned and supervised process of reducing or stopping medications that may no longer be of benefit or may

More information

Disclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships.

Disclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships. The elderly at risk: reducing medications safely to meet life s changes Barbara Farrell BScPhm, PharmD, FCSHP European Society of Hospital Pharmacists Conference March 2017 Disclosure Relevant financial

More information

Deprescribing by Policy. David Gardner Cara Tannenbaum Justin Turner Andrea Murphy Kathleen Coleman Patricia Caetano

Deprescribing by Policy. David Gardner Cara Tannenbaum Justin Turner Andrea Murphy Kathleen Coleman Patricia Caetano Deprescribing by Policy David Gardner Cara Tannenbaum Justin Turner Andrea Murphy Kathleen Coleman Patricia Caetano Disclosure Each presenter declares that they have no actual or potential conflict of

More information

The Use of Sleep Aids in Our Society Today

The Use of Sleep Aids in Our Society Today The Use of Sleep Aids in Our Society Today Kathryn Hansen, BS, CPC, CPMA, REEGT Integration Consultants, LLC Sleep Education Partners Executive Director Kentucky Sleep Society Executive Director Society

More information

Controlled Substances: A survey of tools and resources required by hospital pharmacists

Controlled Substances: A survey of tools and resources required by hospital pharmacists Controlled Substances: A survey of tools and resources required by hospital pharmacists TABLE OF CONTENTS 2018. Canadian Society of Hospital Pharmacists About the survey 1 The Short and Snappy 1 What CSHP

More information

GRADE, EBM and Deprescribing. Kevin Pottie MD CCFP, MClSc, FCFP Associate Professor, Family Medicine, University of Ottawa

GRADE, EBM and Deprescribing. Kevin Pottie MD CCFP, MClSc, FCFP Associate Professor, Family Medicine, University of Ottawa GRADE, EBM and Deprescribing Kevin Pottie MD CCFP, MClSc, FCFP Associate Professor, Family Medicine, University of Ottawa Research is like turning on the light before you clean up the room: it doesn t

More information

A C A D E M I C D E TA I L I N G C H O O S I N G W I S E LY C O N F E R E N C E O C T 2 1, PA M M C L E A N - V E Y S E Y B S C P H A R M D R

A C A D E M I C D E TA I L I N G C H O O S I N G W I S E LY C O N F E R E N C E O C T 2 1, PA M M C L E A N - V E Y S E Y B S C P H A R M D R PPI DEPRESCRIBING Canadian Deprescribing Network (CaDeN) goals are to: Reduce harm by raising awareness and cutting risky prescriptions for seniors by 50% by 2020. Promote health by ensuring access to

More information

Preventing Medication Related Falls

Preventing Medication Related Falls A Team Approach to Deprescribing and Preventing Medication Related Falls Wednesday, February 13 th 2019 Pam Howell THIS WEBINAR IS BEING RECORDED. THE SLIDE DECK AND RECORDING WILL BE EMAILED AFTER THE

More information

OLDER ADULTS & DEPRESCRIBING: TREATMENT

OLDER ADULTS & DEPRESCRIBING: TREATMENT OLDER ADULTS & DEPRESCRIBING: CONTEMPLATION, ASSESSMENT & TREATMENT Jonathan Bertram Faculty/Presenter Disclosure Faculty: Jonathan Bertram Relationships with commercial interests: Grants/Research Support:

More information

TOP 5 DRUGS.. TO AVOID IN THE ELDERLY

TOP 5 DRUGS.. TO AVOID IN THE ELDERLY TOP 5 DRUGS.. TO AVOID IN THE ELDERLY Debbie Kwan, BScPhm., MSc., FCSHP Canadian Geriatrics Society, April 20, 2013 Disclosure of Potential for Conflict of Interest: Financial Disclosure: None Mar 26,

More information

Opioid de-prescribing guidelines?

Opioid de-prescribing guidelines? Opioid de-prescribing guidelines? Feng Chang, RPh, BScPhm, PharmD Associate Professor University of Waterloo, School of Pharmacy Waterloo, Canada #derx2018 Outline Introduction De-prescribing guideline

More information

Daniel S. Sitar, BScPharm, PhD, FCP Professor Emeritus University of Manitoba Editor: Journal of Clinical Pharmacology

Daniel S. Sitar, BScPharm, PhD, FCP   Professor Emeritus University of Manitoba Editor: Journal of Clinical Pharmacology March 8, 2011 Daniel S. Sitar, BScPharm, PhD, FCP Email: sitar@cc.umanitoba.ca Professor Emeritus University of Manitoba Editor: Journal of Clinical Pharmacology DEFINITIONS Pain: The unpleasant sensory

More information

Shared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes

Shared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes Shared decision making for stepdown and stopping decisions Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes 1 Disclosures I have had travel and lodging paid for

More information

Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay

Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay Background Polypharmacy in the Elderly 40% seniors are using 5-9 different classes of

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER

More information

Deprescribing Unnecessary Medications: A Four-Part Process

Deprescribing Unnecessary Medications: A Four-Part Process Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient

More information

Chronic Pain Pharmacist role in the clinic

Chronic Pain Pharmacist role in the clinic Chronic Pain Pharmacist role in the clinic WSPA Annual Meeting 2015 Alvin Goo, PharmD Clinical Associate Professor University of Washington Schools of Pharmacy and Family Medicine Speakers Declaration

More information

Ontario Deprescribing Project Update - July 2014

Ontario Deprescribing Project Update - July 2014 Subscribe Share Past Issues Translate Ontario Deprescribing Project Update - July 2014 View this email in your browser Ontario Deprescribing Project Update July 2014 The evidence based Deprescribing guidelines

More information

WOMEN AND OPIOIDS Media Guide

WOMEN AND OPIOIDS Media Guide Media Guide Canada is in the midst of a serious and growing opioid crisis. Nearly 30% of Canadians report using some form of opioids, such as oxycodone, morphine, codeine, and methadone, in the past five

More information

Michelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier

Michelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier Michelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier University of Toronto Practice Based Research Network Ottawa Practice Enhancement Network Quality & Innovation Program,

More information

Insomnia Treatment in Brief

Insomnia Treatment in Brief Insomnia Treatment in Brief Project ECHO May 7, 2015 Jonathan Emens, M.D. Associate Professor, Departments of Psychiatry and Internal Medicine Oregon Health & Science University Staff Physician and Sleep

More information

Outline. Disclosure. Sleep and the Elderly 1,2. Background

Outline. Disclosure. Sleep and the Elderly 1,2. Background Geriatric Grand Rounds Tuesday, March 31, 29 12: noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this

More information

Medication Use in Older Adults: Updated AGS Beers Criteria

Medication Use in Older Adults: Updated AGS Beers Criteria Medication Use in Older Adults: Updated AGS Beers Criteria Zachary A. Marcum, PharmD, PhD, BCPS Assistant Professor University of Washington, Depertment of Pharmacy School of Pharmacy Agenda 1. Provide

More information

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine A Geriatrician s Perspective on Successful Aging Ariel Green, MD, MPH Assistant Professor of Medicine 1 Disclosures Johns Hopkins Clinical Research Scholars Program American College of Cardiology Foundation

More information

NBPDP Drug Utilization Review Process Update

NBPDP Drug Utilization Review Process Update Bulletin # 802 December 1, 2010 NBPDP Drug Utilization Review Process Update The New Brunswick Prescription Drug Program (NBPDP) employs a Drug Utilization Review (DUR) process which identifies, investigates

More information

WHAT SHOULD WE DO ABOUT BENZODIAZEPINES? Miriam Komaromy, MD Associate Director, Project ECHO August 2014

WHAT SHOULD WE DO ABOUT BENZODIAZEPINES? Miriam Komaromy, MD Associate Director, Project ECHO August 2014 WHAT SHOULD WE DO ABOUT BENZODIAZEPINES? Miriam Komaromy, MD Associate Director, Project ECHO August 2014 EPIDEMIOLOGY OF BENZO USE 7-18% of US population uses a benzo for medical purposes each year Average

More information

Polypharmacy and Deprescribing for Older People

Polypharmacy and Deprescribing for Older People Polypharmacy and Deprescribing for Older People Sarah Hilmer Head of Department, Clinical Pharmacology and Senior Staff Specialist Aged Care, RNSH Conjoint Professor of Geriatric Pharmacology, Sydney University

More information

You May Be at Risk. You are currently taking a non-steroidal anti-inflammatory drug (NSAID):

You May Be at Risk. You are currently taking a non-steroidal anti-inflammatory drug (NSAID): NSAIDS You May Be at Risk You are currently taking a non-steroidal anti-inflammatory drug (NSAID): Aspirin Diclofenac (Voltaren ) Diflunisal (Dolobid ) Etodolac (Lodine ) Ibuprofen (Advil ) Ketoprofen

More information

Inter CGP. College. Objectives: AL SUPPORT. with manufacturer(s) this presentation..

Inter CGP. College. Objectives: AL SUPPORT. with manufacturer(s) this presentation.. 10 th Annual Spring Conference Arizona Geriatrics Society Person-Centered Care: An Inter rprofessional Panel Jeannie K. Lee, PharmD, BCPS, College of Pharmacy, The University of Arizona CGP Learning Objectives:

More information

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016 Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Conflict of Interest & Disclosure Statements The planners and presenters do not have any financial arrangements

More information

Katee Kindler, PharmD, BCACP

Katee Kindler, PharmD, BCACP Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,

More information

Polypharmacy and Polymorbid Patients: Practical Tips and Tricks

Polypharmacy and Polymorbid Patients: Practical Tips and Tricks Polypharmacy and Polymorbid Patients: Practical Tips and Tricks November 2, 2013 Faculty/Presenter Disclosure Faculty: Chris Fan-Lun, BScPhm, ACPR, CGP Pharmacist - Geriatric Medicine Clinical Practice

More information

Optimizing medication in caring for seniors living with frailty: Five perspectives

Optimizing medication in caring for seniors living with frailty: Five perspectives Optimizing medication in caring for seniors living with frailty: Five perspectives Community Care Shanna Trenaman BScH, BScPharm, MAHSR, ACPR, PhD(student) Project Manager for A Collaborative Intervention

More information

Episode 74 Rationale Use of Opioids

Episode 74 Rationale Use of Opioids Prepared by Dr. Keerat Grewal, edited by Dr. Anton Helman, Dec 2015 Episode 74 Rationale Use of Opioids Drs. David Juurlink & Reuben Strayer Opioid Use and Misuse Opioid misuse has become a major public

More information

You May Be at Risk. You are currently taking a sedative-hypnotic drug. Please Bring This Information With You To Your Next Medical Appointment

You May Be at Risk. You are currently taking a sedative-hypnotic drug. Please Bring This Information With You To Your Next Medical Appointment You are currently taking a sedative-hypnotic drug Alprazolam Chlordiazepoxide Clonazepam Diazepam Estazolam Flurazepam Lorazepam Oxazepam Temazepam Triazolam Eszopiclone Zaleplon Zolpidem Please Bring

More information

Taking opioid pain medicine safely

Taking opioid pain medicine safely Taking opioid pain medicine safely Information for patients taking opioid pain medicine Read this booklet to learn about: why you need to wean off your pain medicine how to wean off slowly how to control

More information

Safe Use of Medicines

Safe Use of Medicines Safe Use of Medicines Take your medicines the right way each day! From the National Institute on Aging 1 Table of Contents Read this booklet for practical tips to make sure you are taking all your medicines

More information

Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment

Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment Martin and Tannenbaum BMC Geriatrics (2017) 17:37 DOI 10.1186/s12877-017-0432-5 RESEARCH ARTICLE Open Access Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild

More information

PRACTICAL MANAGEMENT OF INSOMNIA IN THE OFFICE

PRACTICAL MANAGEMENT OF INSOMNIA IN THE OFFICE PRACTICAL MANAGEMENT OF INSOMNIA IN THE OFFICE NORAH VINCENT, PHD., C. PSYCH. PSYCHOLOGIST, WINNIPEG REGIONAL HEALTH AUTHORITY PROFESSOR, DEPARTMENT OF CLINICAL HEALTH PSYCHOLOGY, UNIVERSITY OF MANITOBA

More information

Transplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital

Transplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital Transplant Options for Patients: Choices and Consequences Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital BC Kidney Days October 6 th 2017 Non contributory Conflict of

More information

Alcohol Use In Older People

Alcohol Use In Older People National Institute on Aging AgePage Alcohol Use In Older People Anyone at any age can have a drinking problem. Uncle George always liked his liquor, so his family may not see that his drinking is getting

More information

LONG -TERM USE OF PPIS: INDICATIONS, BENEFITS AND HARMS. Jihane Naous, M.D.

LONG -TERM USE OF PPIS: INDICATIONS, BENEFITS AND HARMS. Jihane Naous, M.D. LONG -TERM USE OF PPIS: INDICATIONS, BENEFITS AND HARMS Jihane Naous, M.D. Objectives Identify the conditions supported by AGA/ACG guidelines necessitating long-term use of daily PPIs, Recognize which

More information

Anthony J. Caprio, MD, CMD, AGSF 1

Anthony J. Caprio, MD, CMD, AGSF 1 Objectives 1) Discuss the dangers of polypharmacy 2) Review potentially inappropriate medications for older adults Doc, I think I am taking too many medications! 3) Develop strategies for prioritizing

More information

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria

More information

AN INTEGRATED APPROACH TO BENZODIAZEPINE DISCONTINUATION: SHARED MEDICAL APPOINTMENTS FOR VETERANS CO-PRESCRIBED OPIOIDS AND BENZODIAZEPINES

AN INTEGRATED APPROACH TO BENZODIAZEPINE DISCONTINUATION: SHARED MEDICAL APPOINTMENTS FOR VETERANS CO-PRESCRIBED OPIOIDS AND BENZODIAZEPINES AN INTEGRATED APPROACH TO BENZODIAZEPINE DISCONTINUATION: SHARED MEDICAL APPOINTMENTS FOR VETERANS CO-PRESCRIBED OPIOIDS AND BENZODIAZEPINES Elizabeth (Betsy) Crowe, PhD Lucille J. Carriere, PhD Objectives

More information

Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians

Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians Executive summary Australia has a significant opportunity to improve the quality use

More information

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative BLCS 1-Clinical Overview Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative Fraser Health Guide To Person-Centered Medication Decisions Factors to Consider When Systematically

More information

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots

More information

Doreen Wan-Chow-Wah, MD, FRCPC Assistant Professor, Division of Geriatric Medicine, Department of Medicine McGill University Health Center Associate

Doreen Wan-Chow-Wah, MD, FRCPC Assistant Professor, Division of Geriatric Medicine, Department of Medicine McGill University Health Center Associate Doreen Wan-Chow-Wah, MD, FRCPC Assistant Professor, Division of Geriatric Medicine, Department of Medicine McGill University Health Center Associate member, Department of Oncology McGill University Medical

More information

Pharmacists in Canada A national survey of Canadians on their perceptions and attitudes towards pharmacists in Canada.

Pharmacists in Canada A national survey of Canadians on their perceptions and attitudes towards pharmacists in Canada. in Canada A national survey of Canadians on their perceptions and attitudes towards pharmacists in Canada. February 2015 Prepared for the Canadian Association Methodology Online Survey Sample Size Survey

More information

Opioid epidemic and PEHP

Opioid epidemic and PEHP Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe

More information

Medication Use in Older Adults

Medication Use in Older Adults Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division

More information

SUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic

SUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic SUBSTANCE ABUSE IN THE ELDERLY The Invisible Epidemic IS IT POSSIBLE TO TEACH AN OLD DOG NEW TRICKS? GUIDELINES All forms of addiction know no age limit. Don t blame all problems on aging. Few realize

More information

Antipsychotic Medications

Antipsychotic Medications TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood

More information

Targeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy

Targeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy Targeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy Presentation Objectives Discuss Polypharmacy In HD patients Define Deprescribing Review results of the pilot study on deprescribing

More information

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES? Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

More information

Cure Sleeping Disorders For Life:Sleep Remedies And Overcoming Insomnia By L.S. Macy READ ONLINE

Cure Sleeping Disorders For Life:Sleep Remedies And Overcoming Insomnia By L.S. Macy READ ONLINE Cure Sleeping Disorders For Life:Sleep Remedies And Overcoming Insomnia By L.S. Macy READ ONLINE If you are searching for a book Cure Sleeping Disorders for Life:Sleep Remedies and Overcoming Insomnia

More information

Addressing the Harms of Prescription Drugs in Canada

Addressing the Harms of Prescription Drugs in Canada www.ccsa.ca www.cclt.ca Addressing the Harms of Prescription Drugs in Canada Innovations & Policy Solutions for Addressing Prescription Drug Abuse April 30, 2014 Rita Notarandrea, Canadian Centre on Substance

More information

Integrating INTERACT into Interim Pharmacist Reviews

Integrating INTERACT into Interim Pharmacist Reviews Integrating INTERACT into Interim Pharmacist Reviews Chad R. Worz, Pharm.D. President, Medication Managers, LLC Adjunct Assistant Professor of Pharmacy Practice, University of Cincinnati, College of Pharmacy

More information

Benzodiazepine abuse code

Benzodiazepine abuse code Search Benzodiazepine abuse code 20-10-2017 The adverse effects of benzodiazepine use and withdrawal can be remarkably similar to the impact of TEENhood trauma. Oxazepam is a short-to-intermediate-acting

More information

If a bad thing is happening to a patient, a drug did it until proven otherwise

If a bad thing is happening to a patient, a drug did it until proven otherwise Dr Vicki s First Rule of Geriatrics Deprescribing in the Elderly Victoria Braund MD, FACP, CMD Director, Division of Geriatrics NorthShore University HealthSystem Medical Director, Brandel Health & Rehab

More information

The Use, Misuse and Abuse of Alcohol, and Psychoactive Drugs among Older Persons

The Use, Misuse and Abuse of Alcohol, and Psychoactive Drugs among Older Persons The Use, Misuse and Abuse of Alcohol, and Psychoactive Drugs among Older Persons Alison A. Moore, MD, MPH Division of Geriatric Medicine David Geffen School of Medicine at UCLA Drinking in Older Adults:

More information

How to prevent iatrogenic risk? benzodiazepine dependence. Aline CORVOL CHU Rennes UMR 6051,

How to prevent iatrogenic risk? benzodiazepine dependence. Aline CORVOL CHU Rennes UMR 6051, How to prevent iatrogenic risk? benzodiazepine dependence Aline CORVOL CHU Rennes UMR 6051, aline.corvol@chu-rennes.fr CONFLICT OF INTEREST DISCLOSURE I have no potential conflict of interest to report

More information

Pain therapeutics. Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain

Pain therapeutics. Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain Pain therapeutics Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain James McCormack, Pharm.D. Professor Faculty of Pharmaceutical Sciences, UBC Common types of pain killers

More information

Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD

Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD 2016 Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD Case Mr. Kid Ney is a 75 y/o patient who has been on dialysis for the last 4 years (PD, then HD). PMHx: HTN, DM,

More information

Produced by The Kidney Foundation of Canada

Produced by The Kidney Foundation of Canada 31 HELPFUL HINT Become an expert on all the medications you re taking. You should know: Name of medication Strength of medication Dose (how much to take) How often and what time of day to take it What

More information

Getting Older ]Wiser: safer drinking. as you age. Massachusetts Department of Public Health Office of Healthy Aging

Getting Older ]Wiser: safer drinking. as you age. Massachusetts Department of Public Health Office of Healthy Aging Massachusetts Department of Public Health Office of Healthy Aging Getting Older ]Wiser: safer drinking as you age Do you drink alcohol even just one drink now and then? Are you over 50? Do you ever take

More information

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Rational prescribing in the older adult. Assoc Prof Craig Whitehead Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade

More information

Cure Sleeping Disorders For Life:Sleep Remedies And Overcoming Insomnia By L.S. Macy READ ONLINE

Cure Sleeping Disorders For Life:Sleep Remedies And Overcoming Insomnia By L.S. Macy READ ONLINE Cure Sleeping Disorders For Life:Sleep Remedies And Overcoming Insomnia By L.S. Macy READ ONLINE Insomnia treatment: Cognitive behavioral therapy instead of - Insomnia treatment: Insomnia is a common sleep

More information

TELUS Health Conference Toronto

TELUS Health Conference Toronto TELUS Health Conference Toronto Dr. Wendy Levinson, MD, OC Chair, Choosing Wisely Canada & International Professor of Medicine, University of Toronto March 23rd, 2016 Wedges of Waste 2 I ve always done

More information

Transforming Care for the Elderly

Transforming Care for the Elderly Transforming Care for the Elderly Session 2: Engaging Pharmacists & Interdisciplinary Care Teams to Improve Prescribing of Antipsychotics & to Reduce Polypharmacy January 11, 2017 3 @cfhi_fcass Welcome

More information

You May Be at Risk. You are taking one of the following sedative-hypnotic medications:

You May Be at Risk. You are taking one of the following sedative-hypnotic medications: You May Be at Risk You are taking one of the following sedative-hypnotic medications: Alprazolam (Xanax ) Bromazepam (Lectopam ) Chlorazepate Chlordiazepoxideamitriptyline Clidinium-chlordiazepoxide Clobazam

More information

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into

More information

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse

More information

Safe Prescribing of Drugs with Potential for Misuse/Diversion

Safe Prescribing of Drugs with Potential for Misuse/Diversion College of Physicians and Surgeons of British Columbia Safe Prescribing of Drugs with Potential for Misuse/Diversion Preamble This document establishes both professional standards as well as guidelines

More information

Controlled Substance and Wellness Agreement

Controlled Substance and Wellness Agreement Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)

More information

A Labour Market Study of Occupational Therapists in Saskatchewan

A Labour Market Study of Occupational Therapists in Saskatchewan A Labour Market Study of Occupational Therapists in Saskatchewan Summary prepared for the: Saskatchewan Society of Occupational Therapists Annual General Meeting May 6, 2017 Doug Elliott Sask Trends Monitor

More information

You May Be at Risk. You are currently taking a proton pump inhibitor (PPI):

You May Be at Risk. You are currently taking a proton pump inhibitor (PPI): PPI You are currently taking a proton pump inhibitor (PPI): Dexlansoprazole (Dexilant ) Esomeprazole (Nexium ) Omeprazole (Losec, Olex ) Lansoprazole (Prevacid, Prevacid Fast Tab ) Pantoprazole sodium

More information

Deprescribing Benzodiazepines in Hospitalized Seniors Using a Patient-Education Intervention

Deprescribing Benzodiazepines in Hospitalized Seniors Using a Patient-Education Intervention Deprescribing Benzodiazepines in Hospitalized Seniors Using a Patient-Education Intervention PRESENTERS Jean Triscott, MD, CCFP (COE) Frances Carr, MBChB, FRCPC Correspondence to: Fcarr@ualberta.ca Frances

More information

Deprescribing: Implementing Less is More

Deprescribing: Implementing Less is More Deprescribing: Implementing Less is More 2017 Geriatric Education Series: Optimal Drug Therapy Christine Eisenhower, PharmD, BCPS Clinical Assistant Professor, URI College of Pharmacy Disclosures This

More information

Polypharmacy and Deprescribing in Older Adults

Polypharmacy and Deprescribing in Older Adults MEDICARE CARE DELIVERY Polypharmacy and Deprescribing in Older Adults Oregon Geriatrics Society October 9, 2016 Arthur Hayward, MD, MBA Internist and Geriatrician, Kaiser Permanente Northwest Session Objectives

More information

Updated Beers Criteria 2012 Potentially Inappropriate Medication Use in Older Adults

Updated Beers Criteria 2012 Potentially Inappropriate Medication Use in Older Adults Updated Beers Criteria 2012 Potentially Inappropriate Medication Use in Older Adults Carrie Allen PharmD, CGP, BCPS mmlearn.org is a program of Morningside Ministries Appreciation is extended to: Baptist

More information

Patient-Centered Deprescribing: Why We All Should Care. Michael J. Koronkowski, PharmD UIC College of Pharmacy

Patient-Centered Deprescribing: Why We All Should Care. Michael J. Koronkowski, PharmD UIC College of Pharmacy Patient-Centered Deprescribing: Why We All Should Care Michael J. Koronkowski, PharmD UIC College of Pharmacy In Case You Were Wondering The views expressed in this presentation are those of the speaker

More information

CONQUERING INSOMNIA & ACHIEVING SLEEP WELLNESS

CONQUERING INSOMNIA & ACHIEVING SLEEP WELLNESS CONQUERING INSOMNIA & ACHIEVING SLEEP WELLNESS "Sleep is the golden chain that ties health and our bodies together." ~ Thomas Dekker ~ Under recognized & Under treated Insomnia Facts Negatively Affects

More information

Relapse Prevention Webinar Agenda Relapse Prevention Planning

Relapse Prevention Webinar Agenda Relapse Prevention Planning Relapse Prevention Webinar Agenda Relapse Prevention Planning Rita Haverkamp, MSN, PMHCNS BC, CNS Expert Care Manager and AIMS Trainer By the end of the webinar you will be able to Describe what a RPP

More information

Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust?

Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? pharmacy Brief Report Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust? Yi Zhi Zhang 1, Justin P. Turner 1,2, * ID, Philippe Martin 1,2 and Cara Tannenbaum

More information

Module. Module. Managing Other Chronic Conditions. Managing Other Chronic Conditions

Module. Module. Managing Other Chronic Conditions. Managing Other Chronic Conditions Managing Other Chronic Conditions 8 Managing Other Chronic Conditions Taking Control of Heart Failure Important Information Please write down important contact information in the space below. You may also

More information

Please Help Support Us By Having Your Flu Jab Here

Please Help Support Us By Having Your Flu Jab Here East Norwich Medical Partnership Thorpe Medical Centre St Williams Way Thorpe St Andrews Norwich NR7 OAJ Flu Vaccinations - 2017 Telephone: 01603 778277 www.eastnorwichmedicalpartnership.co.uk Nov 2017

More information

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine. TRIPROLIDINE New Zealand Consumer Medicine Information What is in this leaflet The medicine you have purchased contains triprolidine. This leaflet is intended to provide information on the active ingredient

More information

Head. ing. More about using medicines safely. Quick info. Doctor s phone number: Pharmacy phone number: 24 hour Poison Control Center

Head. ing. More about using medicines safely. Quick info. Doctor s phone number: Pharmacy phone number: 24 hour Poison Control Center More about using medicines safely Medicines in My Home: www.fda.gov/medsinmyhome Visit the resources in the Student Room Department of Health and Human Services U.S. Food and Drug Administration FDA Consumer

More information

Monitoring polypharmacy and reducing problematic prescribing

Monitoring polypharmacy and reducing problematic prescribing CLINICAL AUDIT Monitoring polypharmacy and reducing problematic prescribing Valid to November 2020 bpac nz better medicin e Audit Focus Patients taking ten or more medicines are at an increased risk of

More information

Geriatric Pharmacology

Geriatric Pharmacology Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological

More information

Update in Geriatrics: Choosing Wisely Primum Non Nocere

Update in Geriatrics: Choosing Wisely Primum Non Nocere Joseph G. Ouslander, M.D. Professor of Clinical Biomedical Science Senior Associate Dean for Geriatric Programs Chair, Department of Integrated Medical Science Charles E. Schmidt College of Medicine Professor

More information

222 pain reliever from canada

222 pain reliever from canada Поиск 222 pain reliever from canada Pain Medications available from Canada Drugs Online. Toll free: 1-877-900-3784 Health Canada has issued new information concerning the use of ASA - caffeine - codeine.

More information

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS René Lento, PhD Lauren Brenner, PhD September 25, 2018 DISCLOSURES None HOME BASE PROGRAM 3 LEARNING OBJECTIVES

More information

Meds and Falls: Keep in Step with your Meds

Meds and Falls: Keep in Step with your Meds Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu

More information

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services: Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata

More information

CARDIOVASCULAR RISK and NSAIDs

CARDIOVASCULAR RISK and NSAIDs CARDIOVASCULAR RISK and NSAIDs Dr. Syed Ghulam Mogni Mowla Assistant Professor of Medicine Shaheed Suhrawardy Medical College, Dhaka INTRODUCTION NSAIDs are most commonly prescribed drugs Recent evidence

More information

CPT David Shaha, MC US Army

CPT David Shaha, MC US Army CPT David Shaha, MC US Army None Thoughts and comments are my own and do not represent the official policy of the Department of the Army, Department of Defense, or United States Government. Clinical Case

More information

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future Daniel S. Sitar Professor Emeritus University of Manitoba Email: Daniel.Sitar@umanitoba.ca March 6, 2018 INTRODUCTION EPIDEMIOLOGY

More information